Mutual of America Capital Management’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
AIM
ACH
BG
NAMA
FAM
Mutual of America Capital Management's CDNA Position: Q3 2022 in Review
Mutual of America Capital Management sold out of CareDx (CDNA) in Q3 2022, closing a stake of 70,792 shares — an estimated $1.52M sold.
Mutual of America Capital Management first reported a position in CDNA in Q1 2019 and held it in 14 quarters. The position peaked at $5.61M in Q2 2021. 182 funds tracked by Wall St. Rank hold CDNA as of Q3 2022.
- Mutual of America Capital Management reported no remaining CareDx position as of Q3 2022 after selling out during the quarter.
- Mutual of America Capital Management sold 70,792 CareDx shares in Q3 2022, an estimated $1.52M.
- Mutual of America Capital Management first reported a position in CareDx in Q1 2019 and held it in 14 quarters.
- Mutual of America Capital Management's CareDx position peaked at $5.61M in Q2 2021.
- 182 funds tracked by Wall St. Rank held CareDx as of Q3 2022.
Based on Mutual of America Capital Management's 13F filing for Q3 2022, filed 8 Nov 2022.